| SC 13G/A | 2023-02-14 | Point72 Asset Management, L.P. | Tricida, Inc. | 132,200 | 0.2% | EDGAR |
| SC 13G/A | 2023-02-14 | CITADEL ADVISORS LLC | Tricida, Inc. | - | 0.4% | EDGAR |
| SC 13G/A | 2023-02-14 | Deep Track Capital, LP | Tricida, Inc. | 4,666,666 | 7.4% | EDGAR |
| SC 13G/A | 2023-02-14 | Frazier Life Sciences Public Fund, L.P. | Tricida, Inc. | 1,500,000 | 2.5% | EDGAR |
| SC 13D/A | 2022-12-16 | Sibling Capital Ventures LLC | Tricida, Inc. | - | 0.0% | EDGAR |
| SC 13D/A | 2022-11-25 | ORBIMED ADVISORS LLC | Tricida, Inc. | 666,667 | 1.1% | EDGAR |
| SC 13G/A | 2022-10-28 | Venrock Healthcare Capital Partners II, L.P. | Tricida, Inc. | 2,982,528 | 5.4% | EDGAR |
| SC 13G | 2022-10-28 | CITADEL ADVISORS LLC | Tricida, Inc. | - | 2.4% | EDGAR |
| SC 13D/A | 2022-10-19 | Sibling Capital Ventures LLC | Tricida, Inc. | 702,411 | 1.3% | EDGAR |
| SC 13G/A | 2022-09-29 | Venrock Healthcare Capital Partners II, L.P. | Tricida, Inc. | 8,881,877 | 16.0% | EDGAR |
| SC 13G/A | 2022-06-07 | Venrock Healthcare Capital Partners II, L.P. | Tricida, Inc. | 5,865,160 | 10.6% | EDGAR |
| SC 13G | 2022-05-16 | Frazier Life Sciences Public Fund, L.P. | Tricida, Inc. | 3,582,093 | 6.3% | EDGAR |
| SC 13D/A | 2022-03-24 | Sibling Capital Ventures LLC | Tricida, Inc. | 777,411 | 1.4% | EDGAR |
| SC 13G/A | 2022-02-14 | Point72 Asset Management, L.P. | Tricida, Inc. | 3,278,236 | 5.9% | EDGAR |
| SC 13G | 2022-02-14 | Venrock Healthcare Capital Partners II, L.P. | Tricida, Inc. | 3,494,851 | 6.3% | EDGAR |
| SC 13D/A | 2021-11-23 | Sibling Capital Ventures LLC | Tricida, Inc. | 777,411 | 1.4% | EDGAR |
| SC 13G | 2021-11-17 | Deep Track Capital, LP | Tricida, Inc. | 5,857,829 | 10.0% | EDGAR |
| SC 13G/A | 2021-09-10 | MORGAN STANLEY | Tricida, Inc. | 619,459 | 1.2% | EDGAR |
| SC 13G | 2021-03-24 | Point72 Asset Management, L.P. | Tricida, Inc. | 2,500,000 | 5.0% | EDGAR |
| SC 13G/A | 2021-02-16 | PRICE T ROWE ASSOCIATES INC /MD/ | Tricida, Inc. | 1,158,637 | 2.3% | EDGAR |